IL326123A - Methods of treating alopecia areata and atopic dermatitis - Google Patents

Methods of treating alopecia areata and atopic dermatitis

Info

Publication number
IL326123A
IL326123A IL326123A IL32612326A IL326123A IL 326123 A IL326123 A IL 326123A IL 326123 A IL326123 A IL 326123A IL 32612326 A IL32612326 A IL 32612326A IL 326123 A IL326123 A IL 326123A
Authority
IL
Israel
Prior art keywords
methods
atopic dermatitis
alopecia areata
treating alopecia
treating
Prior art date
Application number
IL326123A
Other languages
Hebrew (he)
Inventor
Zi Lin
Chongtian Guo
Yufang Lu
Original Assignee
Inmagene Pte Ltd
Zi Lin
Chongtian Guo
Yufang Lu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmagene Pte Ltd, Zi Lin, Chongtian Guo, Yufang Lu filed Critical Inmagene Pte Ltd
Publication of IL326123A publication Critical patent/IL326123A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
IL326123A 2023-07-25 2024-07-25 Methods of treating alopecia areata and atopic dermatitis IL326123A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2023109152 2023-07-25
PCT/CN2024/107416 WO2025021131A1 (en) 2023-07-25 2024-07-25 Methods of treating alopecia areata and atopic dermatitis

Publications (1)

Publication Number Publication Date
IL326123A true IL326123A (en) 2026-03-01

Family

ID=94374222

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326123A IL326123A (en) 2023-07-25 2024-07-25 Methods of treating alopecia areata and atopic dermatitis

Country Status (4)

Country Link
KR (1) KR20260048282A (en)
AU (1) AU2024301506A1 (en)
IL (1) IL326123A (en)
WO (1) WO2025021131A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202600166A (en) * 2024-03-04 2026-01-01 新加坡商創響私人有限公司 Pharmaceutical compositions comprising ox40 targeting antibodies and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809089C (en) * 2010-08-23 2018-12-18 Board Of Regents, The University Of Texas System Anti-ox40 antibodies and methods of using the same
GB201116092D0 (en) * 2011-09-16 2011-11-02 Bioceros B V Antibodies and uses thereof
PE20230255A1 (en) * 2020-04-17 2023-02-07 Hutchison Medipharma Ltd ANTI-OX40 ANTIBODY AND USES THEREOF
WO2022076771A1 (en) * 2020-10-08 2022-04-14 Icahn School Of Medicine At Mount Sinai Compositions for treatment alopecia areata, biomarkers for treatment success, and methods of use thereof
IL301935A (en) * 2020-10-09 2023-06-01 Kyowa Kirin Co Ltd Method for treating ox40 related disease

Also Published As

Publication number Publication date
AU2024301506A1 (en) 2026-02-12
KR20260048282A (en) 2026-04-09
WO2025021131A1 (en) 2025-01-30

Similar Documents

Publication Publication Date Title
IL326123A (en) Methods of treating alopecia areata and atopic dermatitis
LT4126066T (en) Compositions and methods of treating muscle dystrophy
IL307880A (en) Novel ergolines and methods of treating mood disorders
IL299332A (en) Anti-nme antibody and method of treating cancer or cancer metastasis
LT4294257T (en) Method for diagnosing and treating partial lipodystrophy
CA3299710A1 (en) Methods of treating alopecia areata and atopic dermatitis
IL326889A (en) Method of treating hair loss disorders
GB202106202D0 (en) An improved method of treating slurry and improved slurry inoculant
IL300158A (en) Absorbance spectroscopy analyzer and method of use
IL310987A (en) Compositions and methods for treatment of alopecia areata
EP4103187A4 (en) Methods of treating pseudobulbar affect and other emotional disturbances
ES3063538T3 (en) Kit and method for treating skin
IL318840A (en) Tryptamines and methods of treating mood disorders
HK40112718A (en) Compositions and methods for treatment of alopecia areata
GB202107966D0 (en) Composition and method of treatment
IL326251A (en) Treatment of atopic dermatitis
GB202204291D0 (en) Treatment of atopic dermatitis
GB202204211D0 (en) Treatment of atopic dermatitis
CA3285973A1 (en) Methods of treating atopic dermatitis using tapinarof
CA3283861A1 (en) Methods of treating atopic dermatitis
GB202002796D0 (en) Methods of treating tobacco and treated tobacco
IL326170A (en) Upadacitinib for treating alopecia areata
IL305890A (en) Compositions and Methods for the Treatment of Alopecia
HK40103568A (en) Methods for treating atopic dermatitis and related disorders
IL305901A (en) Methods of treating atopic dermatitis with anti il-13 antibodies